Invention Grant
- Patent Title: 1,4-bis(3-aminopropyl)piperazine derivative and its use
-
Application No.: US15558921Application Date: 2016-03-16
-
Publication No.: US10017476B2Publication Date: 2018-07-10
- Inventor: Nicolas Sergeant , Luc Buee , Patricia Melnyk , Marion Gay , Nicolas Le Fur
- Applicant: INSERM (Institut National de la Sante et de la Research Medicale) , CENTRE HOSPITALIER REGIONAL ET UNIVERSITAIRE DE LILLE (CHRU) , UNIVERSITE DE LILLE 2 DROIT ET SANTE
- Applicant Address: FR Paris FR Lille FR Lille
- Assignee: INSERM (Institut National de la Sante et de la Recherche Medicale),CENTRE HOSPITALIER REGIONAL ET UNIVERSITAIRE DE LILLE (CHRU),UNIVERSITE DE LILLE 2 DROIT ET SANTE
- Current Assignee: INSERM (Institut National de la Sante et de la Recherche Medicale),CENTRE HOSPITALIER REGIONAL ET UNIVERSITAIRE DE LILLE (CHRU),UNIVERSITE DE LILLE 2 DROIT ET SANTE
- Current Assignee Address: FR Paris FR Lille FR Lille
- Agency: McDonnell Boehnen Hulbert & Berghoff LLP
- Priority: EP15305384 20150316
- International Application: PCT/EP2016/055633 WO 20160316
- International Announcement: WO2016/146655 WO 20160922
- Main IPC: C07D219/12
- IPC: C07D219/12
Abstract:
The present invention relates to the compound having Formula (I) or pharmaceutically acceptable salts or solvates thereof, and its use in treating and/or preventing a Tauopathy.
Public/Granted literature
- US20180072679A1 NOVEL 1,4-BIS(3-AMINOPROPYL)PIPERAZINE DERIVATIVE AND ITS USE Public/Granted day:2018-03-15
Information query
